Emergent BioSolutions Inc (NYSE:EBS)

53.58
Delayed Data
As of Apr 24
 +0.77 / +1.46%
Today’s Change
46.93
Today|||52-Week Range
73.89
-9.62%
Year-to-Date

Today’s Trading

Previous close52.81
Today’s open52.98
Day’s range52.21 - 54.57
Volume383,164
Average volume (3 months)510,077
Market cap$2.7B
Data as of 4:02pm ET, 04/24/2019

Growth & Valuation

Earnings growth (last year)-36.79%
Earnings growth (this year)+28.59%
Earnings growth (next 5 years)+15.65%
Revenue growth (last year)+39.50%
P/E ratio43.9
Price/Sales3.89
Price/Book2.68

Competitors

 Today’s
change
Today’s
% change
ICPTIntercept Pharmaceut...+0.70+0.77%
LGNDLigand Pharmaceutica...-4.53-3.53%
BHVNBiohaven Pharmaceuti...-0.85-1.33%
RGENRepligen Corp-1.06-1.85%
Data as of 4:02pm ET, 04/24/2019

Financials

Next reporting dateMay 2, 2019
EPS forecast (this quarter)$0.09
Annual revenue (last year)$782.4M
Annual profit (last year)$62.7M
Net profit margin8.01%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, COO &
Director
Robert G. Kramer
Chief Financial Officer, Treasurer &
Executive VP
Richard S. Lindahl
Corporate headquarters
Gaithersburg, Maryland

Forecasts